Laguna Diagnostics Awarded Second U.S. Patent for Rapid Blood Tests to Differentiate Schizophrenia and Bipolar Disorder, Expanding IP Portfolio in $3B Market
Laguna Diagnostics, LLC, a pioneer in blood-based diagnostics for mental health, today announced it has been awarded its second U.S. patent:”Biomarkers for Bipolar Disorder and Schizophrenia”(U.S. Patent No. 12,404,553 B2). This patent expands the company's intellectual property portfolio with breakthrough rapid blood tests that accurately diagnose and differentiate schizophrenia and bipolar disorder-addressing a $3 billion […]